• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前血脂作为Graves病合并甲状腺癌的新预测指标。

Preoperative serum lipids as novel predictors for concomitant thyroid carcinoma in Graves' disease.

作者信息

Gao Xingxing, Liu Mi, Wu Yijun

机构信息

Department of Thyroid Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Center for Rehabilitation Medicine, Department of Anesthesiology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.

出版信息

PeerJ. 2025 Aug 28;13:e19915. doi: 10.7717/peerj.19915. eCollection 2025.

DOI:10.7717/peerj.19915
PMID:40895039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12399084/
Abstract

BACKGROUND

The occurrence of thyroid carcinoma in patients with Graves' disease (GD) has been rising recently. However, the linkage between lipids and the incidence of thyroid carcinoma among GD patients is still not well-established.

OBJECTIVE

The research aims to explore the relationship between serum lipid concentrations and the occurrence of thyroid cancer in patients diagnosed with GD.

METHODS

We conducted a retrospective analysis of data from 512 patients with GD who underwent surgical procedures at our institution between 2015 and 2024. Our study focused on examining the correlations between various patient characteristics and the occurrence of thyroid cancer. Logistic regression models were developed to analyze the predictive factors. Ultimately, we constructed a predictive nomogram to estimate the potential of thyroid cancer in GD patients.

RESULTS

Among the 512 patients with GD, 299 patients were pathologically confirmed as differentiated thyroid carcinoma (DTC) (58.4%). Multivariate analysis revealed that high triglyceride (TAG > 1.185 mmol/L), low high-density lipoprotein (HDL < 1.325 mmol/L), and overweight (body mass index (BMI) ≥ 25) were risk factors for malignancy. In addition, ultrasound characteristics, including nodules in the thyroid, aspect ratio imbalance, hypoechogenicity, irregular borders, and microcalcifications, were risk factors for malignancy. The predictive nomogram demonstrated significant clinical utility, exhibiting an area under the curve (AUC) of 0.91 (95% CI [0.88-0.94]) and 0.91 (95% CI [0.87-0.96]) in the training set and validation set. Moreover, a high level of TAG was a risk factor for central lymph node metastasis and high AJCC staging in GD patients with thyroid carcinoma.

CONCLUSIONS

Our study presents initial findings suggesting that elevated TAG levels, reduced HDL cholesterol levels, and overweight status are individually linked to the incidence of thyroid carcinoma in patients with GD. These results indicate that preoperative serum lipid profiles and BMI can serve as valuable predictors for the occurrence of thyroid carcinoma in this patient population.

摘要

背景

格雷夫斯病(GD)患者中甲状腺癌的发生率近来呈上升趋势。然而,GD患者中脂质与甲状腺癌发病率之间的联系仍未完全确立。

目的

本研究旨在探究血清脂质浓度与诊断为GD的患者甲状腺癌发生之间的关系。

方法

我们对2015年至2024年间在本机构接受手术的512例GD患者的数据进行了回顾性分析。我们的研究重点是检查各种患者特征与甲状腺癌发生之间的相关性。建立逻辑回归模型以分析预测因素。最终,我们构建了一个预测列线图来估计GD患者患甲状腺癌的可能性。

结果

在512例GD患者中,299例经病理证实为分化型甲状腺癌(DTC)(58.4%)。多因素分析显示,高甘油三酯(TAG>1.185 mmol/L)、低高密度脂蛋白(HDL<1.325 mmol/L)和超重(体重指数(BMI)≥25)是恶性肿瘤的危险因素。此外,甲状腺结节、纵横比失衡、低回声、边界不规则和微钙化等超声特征是恶性肿瘤的危险因素。预测列线图显示出显著的临床实用性,在训练集和验证集中的曲线下面积(AUC)分别为0.91(95%CI[0.88 - 0.94])和0.91(95%CI[0.87 - 0.96])。此外,高水平的TAG是GD甲状腺癌患者中央淋巴结转移和高美国癌症联合委员会(AJCC)分期的危险因素。

结论

我们的研究初步结果表明,TAG水平升高、HDL胆固醇水平降低和超重状态分别与GD患者甲状腺癌的发生率相关。这些结果表明,术前血清脂质谱和BMI可作为该患者群体甲状腺癌发生的有价值预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae3/12399084/8ab7e30228d6/peerj-13-19915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae3/12399084/5e9dbd121ce4/peerj-13-19915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae3/12399084/8ab7e30228d6/peerj-13-19915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae3/12399084/5e9dbd121ce4/peerj-13-19915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae3/12399084/8ab7e30228d6/peerj-13-19915-g002.jpg

相似文献

1
Preoperative serum lipids as novel predictors for concomitant thyroid carcinoma in Graves' disease.术前血脂作为Graves病合并甲状腺癌的新预测指标。
PeerJ. 2025 Aug 28;13:e19915. doi: 10.7717/peerj.19915. eCollection 2025.
2
Development and validation of a nomogram prediction model for factors influencing I-refractory Graves' hyperthyroidism.影响碘难治性Graves病甲亢因素的列线图预测模型的开发与验证
Front Endocrinol (Lausanne). 2025 Aug 13;16:1628226. doi: 10.3389/fendo.2025.1628226. eCollection 2025.
3
Thyroid surgery for Graves' disease and Graves' ophthalmopathy.用于治疗格雷夫斯病和格雷夫斯眼病的甲状腺手术。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD010576. doi: 10.1002/14651858.CD010576.pub2.
4
Postoperative nomogram for predicting involved lymph node in differentiated thyroid carcinoma: an observational study.用于预测分化型甲状腺癌淋巴结受累情况的术后列线图:一项观察性研究
Future Oncol. 2025 Sep;21(21):2785-2793. doi: 10.1080/14796694.2025.2543233. Epub 2025 Aug 9.
5
Diagnostic accuracy of thyroid/background ratio in distinguishing Graves' disease from subacute thyroiditis: A comparative study.甲状腺/背景比值在鉴别格雷夫斯病与亚急性甲状腺炎中的诊断准确性:一项对比研究。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jun 20:500199. doi: 10.1016/j.remnie.2025.500199.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Expression levels of T cell-related immune factors and their correlation with thyroid function in Graves' disease with varied serum iodine status: insights into immunopathogenesis.不同血清碘状态的Graves病中T细胞相关免疫因子的表达水平及其与甲状腺功能的相关性:对免疫发病机制的见解
Front Endocrinol (Lausanne). 2025 Aug 15;16:1623881. doi: 10.3389/fendo.2025.1623881. eCollection 2025.
8
Radiomics Nomogram Based on Optimal Volume of Interest Derived from High-Resolution CT for Preoperative Prediction of IASLC Grading in Clinical IA Lung Adenocarcinomas: A Multi-Center, Large-Population Study.基于高分辨率 CT 最优感兴趣区体积的放射组学列线图预测临床 IA 期肺腺癌 IASLC 分级:多中心大样本研究。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241300734. doi: 10.1177/15330338241300734.
9
Unilateral Graves' disease: a case report with concomitant thyroid cancer and systematic review of literature.单侧格雷夫斯病:一例合并甲状腺癌的病例报告及文献系统综述
Minerva Surg. 2025 Jun;80(3):274-281. doi: 10.23736/S2724-5691.25.10685-0. Epub 2025 May 22.
10
The Clinical Utility of Ultrasound and Serological Features Derived Nomogram for the Prediction of Lateral Lymph Node Metastases in Medullary Thyroid Cancer.超声及血清学特征衍生列线图预测甲状腺髓样癌侧方淋巴结转移的临床应用价值
Ultrasound Med Biol. 2025 Oct;51(10):1797-1804. doi: 10.1016/j.ultrasmedbio.2025.06.022. Epub 2025 Jul 25.

本文引用的文献

1
Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.超重作为 Graves 病患者合并甲状腺癌的生物标志物。
Front Endocrinol (Lausanne). 2024 Apr 22;15:1382124. doi: 10.3389/fendo.2024.1382124. eCollection 2024.
2
Stimulated Raman Scattering Microscopy Reveals Aberrant Triglyceride Accumulation in Lymphatic Metastasis of Papillary Thyroid Carcinoma.受激拉曼散射显微镜揭示甲状腺乳头状癌淋巴转移中甘油三酯的异常积累。
Anal Chem. 2024 Apr 16;96(15):5735-5740. doi: 10.1021/acs.analchem.4c00306. Epub 2024 Apr 3.
3
The role of Graves' disease in the development of thyroid nodules and thyroid cancer.
格雷夫斯病在甲状腺结节和甲状腺癌发展中的作用。
Eur Thyroid J. 2023 Jul 12;12(4):e230055. doi: 10.1530/ETJ-23-0055.
4
Metabolic syndrome and thyroid Cancer: risk, prognosis, and mechanism.代谢综合征与甲状腺癌:风险、预后及机制
Discov Oncol. 2023 Feb 22;14(1):23. doi: 10.1007/s12672-022-00599-7.
5
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.2022 年世界卫生组织甲状腺肿瘤分类更新:一种标准化诊断方法。
Endocrinol Metab (Seoul). 2022 Oct;37(5):703-718. doi: 10.3803/EnM.2022.1553. Epub 2022 Oct 4.
6
Association of Metabolic Health and Central Obesity with the Risk of Thyroid Cancer: Data from the Korean Genome and Epidemiology Study.代谢健康和中心性肥胖与甲状腺癌风险的关联:来自韩国基因组与流行病学研究的数据。
Cancer Epidemiol Biomarkers Prev. 2022 Mar 1;31(3):543-553. doi: 10.1158/1055-9965.EPI-21-0255.
7
Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.Graves 病合并甲状腺癌患者的临床特征和预后:一项回顾性多中心研究。
Endocrinol Metab (Seoul). 2021 Dec;36(6):1268-1276. doi: 10.3803/EnM.2021.1227. Epub 2021 Nov 26.
8
Monocyte to high-density lipoprotein cholesterol ratio as an independent risk factor for papillary thyroid carcinoma.单核细胞/高密度脂蛋白胆固醇比值作为甲状腺乳头状癌的独立危险因素。
J Clin Lab Anal. 2021 Nov;35(11):e24014. doi: 10.1002/jcla.24014. Epub 2021 Sep 21.
9
The relationship between lipotoxicity and risk of extrathyroidal extension in papillary thyroid microcarcinoma.脂毒性与甲状腺微小乳头状癌甲状腺外侵犯风险的关系。
Endocrine. 2021 Dec;74(3):646-657. doi: 10.1007/s12020-021-02809-8. Epub 2021 Jun 30.
10
Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study.代谢综合征与甲状腺癌风险:一项全国范围内基于人群的队列研究。
Thyroid. 2020 Oct;30(10):1496-1504. doi: 10.1089/thy.2019.0699. Epub 2020 Jul 15.